Smoldering multiple myeloma associated with a acquired von Willebrand syndrome, successfully treated by daratumumab, lenalidomide and dexamethasone

被引：0
|
作者：
Iarossi, Michael [1 ]
Vekemans, Marie-Christiane Madeleine [2 ]
Weynants, Nicolas [3 ]
Hermans, Cedric [1 ]
机构：
[1] St Luc Hosp, St Lambert, Belgium
[2] Univ Catholique Louvain UCLouvain, Dept Internal Med, Brussels, Belgium
[3] Hop Arlon, Arlon, Belgium
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-427
引用
收藏
页码：S276 / S276
页数：1
相关论文
共 50 条
  • [11] Long-term remission of acquired von Willebrand syndrome associated with multiple myeloma using bortezomib and dexamethasone therapy
    Katagiri, S.
    Akahane, D.
    Amano, K.
    Ohyashiki, K.
    HAEMOPHILIA, 2016, 22 (06) : E557 - E559
  • [12] Relative Dose Intensity of Daratumumab, Lenalidomide, and Dexamethasone in Multiple Myeloma
    Suzuki, Kazuhito
    Gunji, Tadahiro
    Kawashima, Masaharu
    Uryu, Hideki
    Nagao, Riku
    Saito, Takeshi
    Nishiwaki, Kaichi
    Yano, Shingo
    CANCERS, 2025, 17 (03)
  • [13] Paraneoplastic aortitis in a patient with relapsed multiple myeloma successfully treated with daratumumab, bortezomib and dexamethasone
    Ivan Krečak
    Ivana Ruščić
    Josipa Jović Zlatović
    Marijana Šupe
    Marija Valovičić Krečak
    Velka Gverić-Krečak
    Annals of Hematology, 2021, 100 : 1623 - 1624
  • [14] Daratumumab, Ixazomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma
    Kumar, Shaji K.
    Kapoor, Prashant
    Laplant, Betsy
    Phuong-Dung, Liang
    Muchtar, Eli
    Buadi, Francis K.
    Gonsalves, Wilson I.
    Malave, Gabriella C.
    Vossen, Alanna M.
    Dingli, David
    Go, Ronald S.
    Warsame, Rahma M.
    Kourelis, Taxiarchis
    Hwa, Yi L.
    Fonder, Amie
    Hobbs, Miriam A.
    Lust, John A.
    Lacy, Martha Q.
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Leung, Nelson
    Rajkumar, S. Vincent
    Gertz, Morie A.
    BLOOD, 2020, 136
  • [15] Paraneoplastic aortitis in a patient with relapsed multiple myeloma successfully treated with daratumumab, bortezomib and dexamethasone
    Krecak, Ivan
    Ruscic, Ivana
    Zlatovic, Josipa Jovic
    Supe, Marijana
    Krecak, Marija Valovicic
    Gveric-Krecak, Velka
    ANNALS OF HEMATOLOGY, 2021, 100 (06) : 1623 - 1624
  • [16] Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) and Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone (DKRd) As Induction Therapy in Newly Diagnosed Multiple Myeloma
    Tan, Carlyn
    Maclachlan, Kylee H.
    Nemirovsky, David
    Derkach, Andriy
    Hultcrantz, Malin
    Hassoun, Hani
    Mailankody, Sham
    Shah, Urvi A.
    Rajeeve, Sridevi
    Patel, Dhwani
    Shekarkhand, Tala
    Rueda, Colin
    Lahoud, Oscar Boutros
    Shah, Gunjan L.
    Scordo, Michael
    Chung, David
    Landau, Heather
    Giralt, Sergio A.
    Lesokhin, Alexander
    Usmani, Saad Z.
    BLOOD, 2023, 142
  • [17] Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma
    Mateos, Maria-Victoria
    Hernandez, Miguel-Teodoro
    Giraldo, Pilar
    de la Rubia, Javier
    de Arriba, Felipe
    Lopez Corral, Lucia
    Rosinol, Laura
    Paiva, Bruno
    Palomera, Luis
    Bargay, Joan
    Oriol, Albert
    Prosper, Felipe
    Lopez, Javier
    Olavarria, Eduardo
    Quintana, Nuria
    Garcia, Jose-Luis
    Blade, Joan
    Lahuerta, Juan-Jose
    San Miguel, Jesus-F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (05): : 438 - 447
  • [18] B-PRISM (Precision Intervention Smoldering Myeloma): A Phase II Trial of Combination of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma
    Nadeem, Omar
    Redd, Robert A.
    Prescott, Julia
    Metivier, Amada
    Tague, Kelsey
    Romines, Veronica
    Bertoni, Meredith
    Savell, Alexandra
    Medina, Rebekah
    Distaso, Alexandra
    Leblebjian, Houry
    Mo, Clifton C.
    Laubach, Jacob P.
    Sperling, Adam S.
    Richardson, Paul G.
    Ghobrial, Irene M.
    BLOOD, 2021, 138
  • [19] Daratumumab, bortezomib, lenalidomide and dexamethasone in multiple myeloma: the advent of modern quadruplets
    Lanier, Louis
    HEMATOLOGIE, 2024, 30 (02): : 106 - 108
  • [20] Successful treatment of scleromyxedema with daratumumab, lenalidomide and dexamethasone in a patient with multiple myeloma
    Bettolini, Luca
    Bighetti, Stefano
    Maione, Vincenzo
    Ghini, Iacopo
    Segala, Diego
    Calzavara-Pinton, Piergiacomo
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2024, 65 (04) : e104 - e107
12345